Correction of arterial hypertension in the young patients with obesity


Cite item

Full Text

Abstract

The study included 90 patients with obesity I-III and arterial hypertension (AH) I of 16-30 years. Evaluated lipid and carbohydrate metabolism, the condition of the autonomic nervous system, circadian blood pressure, pulse wave velocity in the aorta (PWV), and the effectiveness of the running magnetic field with the help of apparatus «MAGNETIC SIMPATOKOR» in order to reduce blood pressure (BP). The patients were divided into 2 groups: basic - 50 people who underwent magnetic simpatokorrektsiya and control - 40 people received placebo physiotherapy. According to a survey in the group allocated to two subgroups - 1A and 1B. Subgroup 1A amounted to 26 patients with hypersympathicotonia who at repeated definition SPV after simpatokorrektsii noted its significant reduction. In the subgroup 1B included 24 patients with a normal tone and parasimpatikotoniey who SPV has not changed much. After 6 months in patients subgroups 1A BP was on normal numbers, DBS remained at baseline values. In the subgroup 1B patients remained elevated blood pressure. The risk of developing hypertension in a subgroup 1A was 22% in the subgroup 1B - 80% or more. Sympathy correction using magnetic field exposure on the cervical sympathetic ganglion is an effective treatment and prevention of hypertension associated with increased activity of the sympathetic nervous system.

About the authors

V. F Luk’janov

State budgetary educational institution of higher professional education "V.I. Razumovsky Saratov State Medical University"

Saratov, Russia

Yuri Mikhailovich Raigorodskiy

“TRIMA” Ltd

Email: trima@trima.ru
cand. fiz.-math. sci., director-general of “TRIMA” Ltd. Saratov. Russia, 410033

N. V Bolotova

State budgetary educational institution of higher professional education "V.I. Razumovsky Saratov State Medical University"

Saratov, Russia

N. V Posokhova

State budgetary educational institution of higher professional education "V.I. Razumovsky Saratov State Medical University"

Saratov, Russia

References

  1. Miller J.D., Aronis K.N., Chrispin J., Patil K.D., Marine J.E., Martin S.S. et al. Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation. J. Am. Coll. Cardiol. 2015; 66 (25): 2899-906. doi: 10.1016/j.jacc.2015.10.047.
  2. Handler J. Clinical challenges in diagnosing and managing adult hypertension. Cleve. Clin. J. Med. 2015; 82 (12, Suppl. 2): S36-41. doi: 10.3949/ccjm.82.s2.06.
  3. Dimova R., Tankova T., Chakarova N., Groseva G., Dakovska L. Cardiovascular autonomic tone relation to metabolic parameters and hsCRP in normoglycemia and prediabetes. Diabet. Res. Clin. Pract. 2015; 109 (2): 262-70. doi: 10.1016/j.diabres.2015.05.024.
  4. Jordan J., Yumuk V., Schlaich M., Nilsson P.M., Zahorska-Markiewicz B., Grassi G., et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J. Hypertens. 2012; 30: 1047-55.
  5. Rahman S.A., Adjeroh D. Surface-based body shape index and its relationship with all-cause mortality. PLoS One. 2015; 10 (12): 25-7. doi: 10.1371/journal.pone.0144639.
  6. Драпкина О.М., Корнеева О.Н., Ивашкин В.Т. Активация симпатической нервной системы при ожирении. Как повлиять на энергетический гомеостаз. Артериальная гипертензия. 2011; 2 (17): 102-7.
  7. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010; 55: 1318-27.
  8. Veerasamy M., Ford G.A., Neely D., Bagnall A., MacGowan G., Das R., Kunadian V. Association of aging, arterial stiffness, and cardiovascular disease: a review. Cardiol. Rev. 2014; 22 (5): 223-32. doi: 10.1097/CRD.0000000000000009.
  9. Давидович И.М., Винокурова И.Г. Структура и функция сосудистой стенки у людей с артериальной гипертензией молодого возраста: влияние основных факторов сердечно-сосудистого риска. Терапевт. 2013; (6): 17-24.
  10. Свиряев Ю.В., Звартау Н.Э. Сосудистое ремоделирование: новые цели - проверенные способы их достижения. Артериальная гипертензия. 2010; 2 (17): 181-4.
  11. Чубенко Е.А., Беляева О.Д., Баженова Е.А., Каронова Т.Л., Нифонтов С.Е., Беркович О.А., Баранова Е.И. Опыт применения моксонидина у больных метаболическим синдромом. Артериальная гипертензия. 2014; 2 (20): 128-35.
  12. Абрамович С.Г., Куликов А.Г., Долбилкин А.Ю. Общая магниотерапия при артериальной гипертонии. Физиотер., бальнеол. и реабил. 2014; (5): 50-55.
  13. Посохова Н.В., Болотова Н.В. Ожирение как фактор формирования артериальной гипертензии у детей и подростков. Педиатрия. 2015; 94 (5): 127-31.

Copyright (c) 2016 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies